hydroxyproline has been researched along with Bronchopulmonary Dysplasia in 5 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to explore the effect of losartan, an angiotensin II type 1 receptor antagonist, on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease (CLD) and its possible mechanisms." | 7.74 | [Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease]. ( Chen, N; Li, JJ; Xue, XD, 2007) |
| " This study aimed to explore the effect of losartan, an angiotensin II type 1 receptor antagonist, on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease (CLD) and its possible mechanisms." | 3.74 | [Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease]. ( Chen, N; Li, JJ; Xue, XD, 2007) |
| "Lung hydroxyproline content was increased in hyperoxia-exposed wild-type, but not in cat S-deficient lungs." | 1.34 | Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. ( Bingol-Karakoc, G; Cataltepe, S; Hirakawa, H; Karaaslan, C; Mariani, TJ; Pierce, RA; Saad, A; Shapiro, SD; Shi, GP; Starcher, B; Weber, E; Weng, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, H | 1 |
| Pierce, RA | 1 |
| Bingol-Karakoc, G | 1 |
| Karaaslan, C | 1 |
| Weng, M | 1 |
| Shi, GP | 1 |
| Saad, A | 1 |
| Weber, E | 1 |
| Mariani, TJ | 1 |
| Starcher, B | 1 |
| Shapiro, SD | 1 |
| Cataltepe, S | 1 |
| Chen, N | 1 |
| Li, JJ | 1 |
| Xue, XD | 1 |
| Co, E | 2 |
| Chari, G | 2 |
| McCulloch, K | 1 |
| Vidyasagar, D | 2 |
| Cherukupalli, K | 1 |
| Larson, JE | 1 |
| Rotschild, A | 1 |
| Thurlbeck, WM | 1 |
| Roohey, T | 1 |
| McCulloch, KM | 1 |
5 other studies available for hydroxyproline and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury.
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Cathepsins; Col | 2007 |
[Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Huma | 2007 |
Dexamethasone treatment suppresses collagen synthesis in infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Collagen; Combined Modality Therapy; Creatinine; Dexamethasone; Female; | 1993 |
Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Collagen; Desmosine; DNA; Humans; Hyaline Membrane | 1996 |
On urinary hydroxyproline excretion in preterm infants who later develop bronchopulmonary dysplasia.
Topics: Biomarkers; Bronchopulmonary Dysplasia; Humans; Hydroxyproline; Infant, Newborn; Infant, Premature; | 1996 |